West Pharmaceutical Services (WST) Inventory Average (2010 - 2026)

West Pharmaceutical Services has disclosed Inventory Average across 17 years of filings, most recently posting $448.2 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $448.2 million, up 17.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $448.2 million (up 17.08% YoY), and the FY2025 annual result was $410.4 million, up 1.13% from the prior year.
• Inventory Average came in at $448.2 million for Q1 2026 at West Pharmaceutical Services, up from $441.0 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $448.2 million in Q1 2026 to a low of $382.8 million in Q1 2025.
• The 5-year median for Inventory Average is $424.6 million (2024), against an average of $420.8 million.
• Across the five-year window, Inventory Average rose 26.35% in 2022 and dropped 11.44% in 2025, its largest moves.
• West Pharmaceutical Services' Inventory Average stood at $414.0 million in 2022, then grew by 4.66% to $433.2 million in 2023, then slipped by 10.19% to $389.1 million in 2024, then increased by 13.33% to $441.0 million in 2025, then rose by 1.66% to $448.2 million in 2026.
• The last three Inventory Average figures came in at $448.2 million (Q1 2026), $441.0 million (Q4 2025), and $429.6 million (Q3 2025), per Business Quant data.